Financial institutions are 300 times more vulnerable to cyberattacks than any other industry.
FPIs have turned net sellers in 2022 after being net buyers in the last three years.
'By filing a belated return, you can avoid the consequences of non-disclosure of income.' 'You can also avoid a notice from the I-T department for not filing an ITR.'
Domestically, Indians are exploring popular beach destinations, the hills of Himachal Pradesh and Uttarakhand, and the North-Eastern region as well.
Here's how leading brokerages and research houses expect 2023 to play out for the equity markets, and their sector preferences.
'Airports must look at their maximum capacity to handle passengers.'
The system of 'selecting' an election commissioner, which is before the Supreme Court, must be institutionalised.
'Yet the market didn't do all that badly because it was cushioned by domestic inflows.'
'If we are to be a contributor to the economy, we have to reduce carbon and imports.' 'We will achieve both -- that's our target.'
NRIs can repatriate the proceeds from the sale of a residential property in India, provided they meet a few conditions.
'New record for the Nifty50 is only a question of when.'
'Career paths are no longer linear as professionals look to build a more holistic career portfolio that is true to their professional and financial goals.'
Any currency design change must be approved by the RBI central board and the central government.
'A patient visits for any other treatment, but a routine Covid test finds him to be positive.' 'Not only are they, but their whole family is also coming out to be positive.'
'We now understand things that we have to correct.'
'Earning expectations remain strong.'
You can avail of tax deduction on expenses incurred on preventive health check-ups. This provision is beneficial to younger people who don't exhaust their Section 80D limit with their health insurance premium.
Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.
'Antibodies remain in the blood for at least seven to nine months.'
After dropping to a low of Rs 1,298 apiece, the stock finished at Rs 1,380, its lowest level since November 22, the second day of listing.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances